Hologic (Nasdaq:HOLX) today announced preliminary first-quarter revenue results for the three months ended Dec. 31, 2022. Marlborough, Massachusetts–based Hologic expects to report revenues of approximately $1.07 billion. That represents a 27% decrease from the same period of the previous year. However, it comes in above Hologic’s guidance range of $940 million to $990 million set […]
Women's Health
Study backs use of Masimo hemoglobin monitoring during cesarean delivery
Masimo (Nasdaq:MASI) today announced positive data from a study of its hemoglobin monitoring for patients undergoing cesarean section. The study observed patients undergoing elective cesarean section (CS) with antepartum hemorrhage. Researchers used noninvasive, continuous hemoglobin monitoring with Masimo SpHb. The study demonstrated significant positive correlations between SpHb and invasive hemoglobin (Hb) values. “In patients undergoing […]
Minerva Surgical CEO retires, former Activ Surgical head Todd Usen named as replacement
Minerva Surgical (Nasdaq:UTRS) announced that it appointed Todd Usen to replace retiring President and CEO David Clapper. Clapper served as president and CEO of the abnormal uterine bleeding (AUB) treatment developer since 2011. Minerva selected Former Activ Surgical CEO Todd Usen to take over those roles and become a member of the board, effective Jan. […]
Movano unveils medical-grade smart ring for women’s health
Movano Health (Nasdaq:MOVE) announced today that it unveiled its Evie smart ring designed specifically for women. Pleasanton, California-based Movano designed Evie to offer intelligence and comfortability in a sleek appearance. It provides users with medical-grade health data for translation into personalized insights delivered through a mobile app. The system requires no monthly subscription, according to […]
Medtronic enrolls first patients in Hugo surgical robot clinical trial
Medtronic (NYSE:MDT) announced today that it enrolled the first patient in its Expand URO U.S. clinical trial for the Hugo surgical robot. Dr. Michael R. Abern at Duke University Hospital (Durham, North Carolina) performed the procedure. He used the Hugo robotic-assisted surgery (RAS) system for a robotic-assisted prostatectomy procedure. “This is an exciting moment,” said Abern. […]
FDA clears RF Medical radiofrequency ablation system
RF Medical announced today that the FDA cleared its Mygen M-3004 generator and specialized electrodes, including Myoblate. The Korea-based thermal ablation system manufacturer made both products commercially available in the U.S. According to a news release, the technologies help to modernize the standard of care for minimally invasive practices. “The world’s medical device market is […]
Olympus launches power morcellator with FDA-advised changes
Olympus today announced the U.S. market launch of its Moresolution power morcellator, saying it supports the safe use of the gynecologic devices under FDA guidance. In 2020, the FDA issued final guidance on power morcellators after the devices faced questions about potentially spreading cancer. The agency recommended limiting laparoscopic power morcellation (LPM) to use with […]
Hologic stock rises on Street-beating Q4 despite continued supply chain challenges
Hologic (Nasdaq:HOLX) shares are up today — a day after fourth-quarter results that came in well ahead of the consensus forecast. Shares of HOLX were up more than 8% at $73.80 apiece by afternoon trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up more than 2%. The […]
iCad, Solis Mammography partner on AI for cardiovascular disease
iCad (Nasdaq:ICAD) announced today that it entered into a collaboration with Solis Mammography to define cardiovascular risk. The development and commercial collaboration revolves around producing an artificial intelligence (AI) solution. This solution potentially quantifies the presence of breast arterial calcifications in a mammogram to assess the risk of cardiovascular disease (CVD). It uses data obtained […]
Study backs FEMSelect meshless pelvic floor fixation system
FEMSelect announced positive results from a four-year prospective follow-up evaluation of its EnPlace system. Newark, Delaware-based FEMSelect designed its EnPlace system as a minimally invasive, meshless approach to pelvic floor ligament fixation. The device attaches sutures to ligaments of the pelvic floor. It represents an alternative to heavily scrutinized pelvic mesh devices. Medical investigators found […]
J&J settles big Australian pelvic mesh case
Johnson & Johnson (NYSE: JNJ) has settled an Australian pelvic mesh class action suit for AU$300 million (roughly U.S. $205 million), according to media reports. Shine Lawyers, which handled the suit, confirmed the settlement. It still requires court approval. More than 11,000 claimants in Australia had sought relief, according to Reuters. In a statement shared […]